Its shares have declined by 50% over this period. But Pfizer's path to a rebound (unlike Teladoc's) seems clear. Even aside ...

Morgan Stanley ($MS) has issued a less optimistic outlook on the performance of the shares of American pharmaceutical giant ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

The latest trading day saw Pfizer (PFE) settling at $25.78, representing a +1.78% change from its previous close.

Healthcare stocks have lagged the broader market for the past three years, weighed down by post-COVID earnings volatility, ...

Pfizer (PFE) is reiterated as a Buy, supported by the world's largest drug pipeline and trading below intrinsic value, ...

As of Monday, December 08, Nurix Therapeutics, Inc.’s NRIX share price has surged by 18.05%, which has investors questioning if this is right time to sell.

As of the close of business on December 5, around 60% of the 26 Wall Street analysts with recommendations on Pfizer have a ...

Finally, Merck is an excellent dividend stock. It offers a juicy forward yield of 3.2% and has increased its payouts by 93.8% ...

There is plenty to be wary of with this drugmaker, but there are also reasons to be optimistic.

Pfizer stock offers 30% upside with strong non-COVID franchises, margin expansion, and pipeline potential. Click here to read ...

The Prudent Speculator is an investment newsletter that has been published monthly since 1977. Buckingham and his team run four value-stock portfolios. The flagship Prudent Speculator Portfolio has ...